Insights
Exploring Cannabinoids in the Battle Against COVID-19: A Comprehensive Review
LOS ANGELES- In the ongoing quest to understand and combat COVID-19, a recent study titled “Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19,” presents intriguing possibilities offered by cannabinoids. Authored by researchers Cassidy Scott, Stefan Hall, Juan Zhou, and Christian Lehmann, the review meticulously examines the potential role of cannabis plant ...
Filament Health Achieves Milestone with First Botanical Psilocybin Export to Australia
NEW YORK – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS), a trailblazer in the realm of natural psychedelic drug development, announced a significant milestone in its global expansion with the successful export of PEX010, its botanical psilocybin drug candidate, to Perth, Western Australia. This shipment, received by Reset Mind Sciences Ltd., a subsidiary ...
Pentagon Responds to Rising Overdose Deaths with New Drug Policy Initiatives
LOS ANGELES- In an unprecedented move, the Department of Defense is set to implement a new policy in 2024 to address the escalating issue of drug overdoses within the United States military. This initiative, prompted by a surge in such incidents, involves two key components: tracking military overdoses and providing naloxone, commonly known as NARCAN, ...
Exploring Cannabinoids as a Potential Treatment Avenue for COVID-19 and Long-COVID
LOS ANGELES- In a groundbreaking development in the ongoing battle against COVID-19, a team of Canadian researchers has presented a comprehensive review that suggests a potential therapeutic role for cannabinoids. The study, entitled “Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19,” published in the Journal of Clinical Medicine, delves into how ...
California Cannabis Regulators Issue Health-Related Recalls on Products
LOS ANGELES- In a statement released on Wednesday, the DCC outlined the details of two separate recalls involving cannabis products. The recalls underscore ongoing regulatory vigilance in the burgeoning cannabis industry, particularly in California, a state at the forefront of cannabis legalization and regulation. California’s Department of Cannabis Control (DCC) has recently initiated mandatory and ...
New York Cannabis Control Board Approves Two More Operators for Recreational Market
NEW YORK — In a remarkably swift meeting on Friday, the New York Cannabis Control Board (CCB) made a significant decision, approving the transition of two additional multi-state operators (MSOs) from the medical to the recreational cannabis market. This move brings the total number of transitioning MSOs to eight, marking a notable expansion in New ...
Maine’s Cannabis Market Hits Record Highs
LOS ANGELES- The cannabis industry in Maine achieved a remarkable milestone in 2023, with retail revenues surpassing $200 million, despite a challenging backdrop of declining prices that have troubled operators. This surge represents a significant leap from the previous year, marking a 36% increase in sales and a notable upturn in consumer transactions. As reported ...
VA to Explore Psychedelics for PTSD and Depression
LOS ANGELES- In a groundbreaking move, the Department of Veterans Affairs (VA) is funding research into the therapeutic potential of psychedelics for treating mental health conditions like post-traumatic stress disorder (PTSD) and depression in veterans. This initiative, a first in decades, signals a significant shift in the VA's approach to mental health treatment. The VA's ...
West Virginia Eyes Cannabis Legalization in Fight Against Fentanyl Crisis
NEW YORK— As West Virginia's legislative session unfolds, the topics of cannabis legalization and the fentanyl crisis are taking center stage. Senate President Craig Blair, speaking at a press event on January 5, indicated that cannabis could play a role in combating the state's escalating fentanyl problem, although he was unsure if legalization would occur ...
Ohio Governor Advocates for Ban on Intoxicating Hemp Products Amid Cannabis Regulation Efforts
LOS ANGELES— Ohio Governor Mike DeWine has urged state legislators to ban hemp-derived cannabinoids, including delta-8 THC, citing potential risks to children. The call for legislative action comes as Ohio prepares to navigate the complexities of recreational cannabis regulation following its recent legalization. DeWine, addressing the issue at a press conference, expressed concern over the ...
Wisconsin Navigates the Complex Path Toward Cannabis Legalization Amid Political Divide
LOS ANGELES- Wisconsin’s journey toward cannabis legalization is unfolding against a backdrop of political complexities, with Governor Tony Evers, a Democrat, indicating openness to a Republican-led medical cannabis legalization plan. This stance emerges as broader cannabis policy reform remains unlikely due to the state's Republican-majority legislature. Governor Evers, a proponent of recreational cannabis legalization, has ...
Challenges Persist in New York’s Transition to Legal Cannabis Market Amid Illicit Trade
NEW YORK- As New York's legal cannabis market surpasses its first year, significant challenges remain in curbing the state's rampant illicit cannabis trade. Despite efforts by the New York Office of Cannabis Management (OCM), the vast scale of underground operations poses questions about the effectiveness of the state's strategy to transition to a fully licensed ...
Mississippi Health Officials Issue Retesting Order for Medical Cannabis Products
LOS ANGELES- In a significant move to ensure public safety, Mississippi health officials have mandated the retesting of approximately 70% of the medical cannabis products available in the state. This decision comes in response to an anonymous tip alleging the contamination of these products with pesticides. The state Department of Health, acting on the information ...
Cybin Inc. Advances Psychedelic Therapy with Promising Phase 2 Results and Upcoming Trials
LOS ANGELES- Cybin Inc., a clinical-stage biopharmaceutical company at the forefront of psychedelic-based mental health treatments, recently announced encouraging results from its Phase 2 study of CYB003 for Major Depressive Disorder (MDD) and outlined key milestones for its upcoming clinical trials. The company's Phase 2 findings revealed a significant breakthrough in treating MDD. The study ...
AMA Introduces Psychedelic Therapy Codes Amidst FDA Review of Prescription MDMA
-LOS ANGELES The American Medical Association (AMA) has taken a significant step in the realm of psychedelic therapy by introducing specific codes for these treatments. This development aligns with the Food and Drug Administration's (FDA) ongoing evaluation of MDMA as a potential prescription medication for post-traumatic stress disorder (PTSD). In July, the AMA, in collaboration ...
Silo Pharma Advances in Development of Ketamine-Loaded Implant for Chronic Pain Treatment
LOS ANGELES- In a significant step towards innovating chronic pain management, developmental-stage biopharmaceutical company Silo Pharma, Inc. (Nasdaq: SILO) has reported notable progress in the development of SP-26, a ketamine-loaded implant designed for home treatment of fibromyalgia and other chronic pain conditions. Working collaboratively with Sever Pharma Solutions, Silo Pharma is conducting analytical testing and ...
New Mexico Achieves Record-Breaking Cannabis Sales in December
LOS ANGELES— New Mexico's cannabis market has set a new monthly sales record in December, with total sales surpassing $50.4 million, a significant milestone in the state's burgeoning legal cannabis industry. The latest figures released by the New Mexico Cannabis Control Division reveal a robust growth trajectory, with the state's total cannabis sales since market ...
Tennessee Hemp Industry Faces Potential Setback from New Regulatory Proposals
LOS ANGELES- Tennessee's burgeoning hemp industry is confronting potential challenges due to new regulatory proposals by the state's Department of Agriculture. Business owners and growers within the state are voicing concerns that these new rules, if implemented, could significantly hinder the industry's growth and viability. In a recent legislative move, the Tennessee General Assembly passed ...
atai Life Sciences Reveals Promising Results from EMP-01 Phase 1 Study
NEW YORK- atai Life Sciences, a clinical-stage biopharmaceutical company, has announced encouraging results from its Phase 1 study of EMP-01, an orally administered R-enantiomer of MDMA. This study, a significant step in the company's mission to revolutionize mental health treatment, was designed to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of EMP-01. The ...
Oakland Tragedy Highlights Urgent Need for Federal Cannabis Policy Reform
LOS ANGELES- A somber mood envelops the Oakland Police Department following the tragic death of Officer Tuan Le, who was fatally shot while responding to a burglary at a cannabis dispensary. The incident underscores a pressing national issue: the impact of federal inaction on cannabis policy, which significantly elevates risks for dispensary workers, the public, ...
Virginia’s Legislative Shift: A New Hope for Adult-Use Cannabis Sales
NEW YORK- The political landscape in Virginia is undergoing a significant transformation as Democrats regain full control of the General Assembly, bringing renewed optimism for the launch of an adult-use cannabis market. This development comes with high expectations, as projections suggest the market could exceed $1 billion in sales within a few years, positioning Virginia ...
Alberta Introduces Progressive Cannabis Regulations to Boost Market and Consumer Access
LOS ANGELES- In a landmark move, Alberta, Canada, has announced new regulations set to invigorate the cannabis industry within the province, signaling a significant shift in the landscape of legal cannabis since its nationwide legalization in 2018. These regulations, poised to take effect on January 31, 2024, are expected to enhance both retailer flexibility and ...
Johns Hopkins Launches Pioneering Study on Medical Cannabis with $10 Million Grant
LOS ANGELES- In a significant development in the realm of medical cannabis research, Johns Hopkins University School of Medicine has embarked on an ambitious project to track 10,000 medical cannabis patients across the United States. This extensive study, fueled by a $10 million grant from the National Institute on Drug Abuse (NIDA), aims to shed ...
Australia’s First Psychedelic-Assisted Therapy Clinic Receives Key Endorsement, Paving Way for Innovative Mental Health Treatments
NEW YORK- In a significant milestone for mental healthcare in Australia, Incannex Healthcare Ltd's subsidiary, Clarion Clinics, has received the Human Research Ethics Committee (HREC) endorsement for its pioneering psychedelic-assisted therapy clinic in Melbourne. This endorsement represents a crucial step in the administration of psychedelic drugs for therapeutic purposes in Australia, especially for conditions like ...
Pennsylvania Advances Fair Competition in Medical Cannabis with SB 773
NEW YORK- Governor Josh Shapiro has signed into law SB 773, a bill poised to revolutionize Pennsylvania's medical cannabis market by promoting fair competition and challenging the dominance of major multistate operators (MSOs). This legislation represents a significant shift from the existing constraints that have hindered the growth of small and medium-sized businesses in the ...
